Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Cancer Research|January 10, 2002
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsMarc Ladanyi, Cristina R Antonescu, Denis H Leung, et al.
Cancer Research|January 7, 2006
Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 geneLeendert H J Looijenga, Remko Hersmus, Ad J M Gillis, et al.
Cancers|October 16, 2025
Childhood, Adolescent and Young Adult Poor-Prognosis RhabdomyosarcomaAjla T Wasti, Gianni Bisogno, Raquel Hladun, et al.
American Journal of Human Genetics|September 6, 2008
DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndromeClaudia Canzonetta, Claire Mulligan, Samuel Deutsch, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Corinne M Linardic, Anna Kelsey, et al.
JCO Precision Oncology|January 18, 2023
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric RhabdomyosarcomaNathalie S M Lak, Lieke M J van Zogchel, Lily Zappeij-Kannegieter, et al.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.
Cell Death Discovery|November 3, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcomaFrancesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili, et al.
Oncotarget|October 21, 2017
Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependentAnke E M van Erp, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen, et al.
Pageof 11